Gene-expression profiling of experimental autoimmune encephalomyelitis

被引:15
作者
Mix, E
Pahnke, J
Ibrahim, SM
机构
[1] Univ Rostock, Dept Immunol, D-18055 Rostock, Germany
[2] Univ Rostock, Dept Neurol, D-18055 Rostock, Germany
关键词
EAE; multiple sclerosis; oligonucleotide-microarrays; QTL;
D O I
10.1023/A:1020925425780
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Experimental autoimmune encephalomyelitis (EAE) is a mouse model that serves as an experimental tool for studying the etiology, pathogenesis, as well as new therapeutic approaches of multiple sclerosis (MS). EAE is a polygenic chronic inflammatory demyelinating disease of the nervous system that involves the interaction between genetic and environmental factors. Previous studies have identified multiple quantitative trait loci (QTL) controlling different aspects of disease pathogenesis. However, progress in identifying new susceptibility genes outside the MHC locus has been slow. With the advent of new global methods for genetic analysis such as large-scale sequencing, gene expression profiling combined with classic linkage analysis and congenic and physical mapping progress is considerably accelerating. Here we review our preliminary work on the use of gene expression mapping to identify new putative genetic pathways contributing to the pathogenesis of EAE.
引用
收藏
页码:1157 / 1163
页数:7
相关论文
共 51 条
[1]  
BAKER D, 1995, J IMMUNOL, V155, P4046
[2]   Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis [J].
Bernard, CCA ;
Johns, TG ;
Slavin, A ;
Ichikawa, M ;
Ewing, C ;
Liu, J ;
Bettadapura, J .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (02) :77-88
[3]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[4]  
Broman KW, 2001, LAB ANIMAL, V30, P44
[5]  
Butterfield RJ, 1998, J IMMUNOL, V161, P1860
[6]  
Butterfield RJ, 1999, J IMMUNOL, V162, P3096
[7]   Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis [J].
Butterfield, RJ ;
Blankenhorn, EP ;
Roper, RJ ;
Zachary, JF ;
Doerge, RW ;
Teuscher, G .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (02) :637-645
[8]   The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease [J].
Chabas, D ;
Baranzini, SE ;
Mitchell, D ;
Bernard, CCA ;
Rittling, SR ;
Denhardt, DT ;
Sobel, RA ;
Lock, C ;
Karpuj, M ;
Pedotti, R ;
Heller, R ;
Oksenberg, JR ;
Steinman, L .
SCIENCE, 2001, 294 (5547) :1731-1735
[9]   The immunobiology of multiple sclerosis: An autoimmune disease of the central nervous system [J].
Conlon, P ;
Oksenberg, JR ;
Zhang, JQ ;
Steinman, L .
NEUROBIOLOGY OF DISEASE, 1999, 6 (03) :149-166
[10]   Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice [J].
Croxford, JL ;
ONeill, JK ;
Baker, D .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 74 (1-2) :205-211